Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Riñones
33
Enfermedades
24
Enfermería
13
Fisiología
8
Insuficiencia renal
7
Insuficiencia renal crónica
6
Nutrición
5
Tratamiento
5
Aparato urinario
4
Dietoterapia
4
Diálisis
4
Nefrología
4
Química clínica
4
Trasplantes de riñones
4
Diagnóstico
3
Licenciado en Enfermería
3
Aspectos nutricionales
2
Atención al paciente
2
Atlas
2
Cirugía
2
Dieta para enfermos
2
Farmacología
2
Farmacología clínica
2
Fisiología renalAparato urinario
2
Fisiopatología
2
Fisiopatología de riñones
2
Hemodiálisis
2
Medicina
2
Medicina clínica
2
Urología pediátrica
2
-
99081por Toprak, Betül, Brandt, Stephanie, Brederecke, Jan, Gianfagna, Francesco, Vishram-Nielsen, Julie K K, Ojeda, Francisco M, Costanzo, Simona, Börschel, Christin S, Söderberg, Stefan, Katsoularis, Ioannis, Camen, Stephan, Vartiainen, Erkki, Donati, Maria Benedetta, Kontto, Jukka, Bobak, Martin, Mathiesen, Ellisiv B, Linneberg, Allan, Koenig, Wolfgang, Løchen, Maja-Lisa, Di Castelnuovo, Augusto, Blankenberg, Stefan, de Gaetano, Giovanni, Kuulasmaa, Kari, Salomaa, Veikko, Iacoviello, Licia, Niiranen, Teemu, Zeller, Tanja, Schnabel, Renate B“…METHODS AND RESULTS: In pooled European community cohorts (n = 42 280 individuals), 14 routinely available biomarkers mirroring distinct pathophysiological pathways including lipids, inflammation, renal, and myocardium-specific markers (N-terminal pro B-type natriuretic peptide [NT-proBNP], high-sensitivity troponin I [hsTnI]) were examined in relation to incident AF using Cox regressions and distinct ML methods. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99082“…This dose was repeated for 2 months, and after that, the blood samples were collected to estimate hepatic and renal injury markers, lipid profiles, and oxidative stress parameters. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99083por Mizher, Aya, Hammoudi, Heba, Hamed, Farah, Sholi, Abrar, AbuTaha, Adham, Abdalla, Mazen A., Jaber, Mohammad M., Hassan, Mohannad, Koni, Amer A., Zyoud, Sa’ed H.“…End-stage renal disease (ESRD) is a common chronic disease worldwide that requires hemodialysis. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99084por van Gemert, J.P., Steenberg, F.J., Buter, C. van Leer, Kerstjens, H.A., Akkerman, O.W., Verschuuren, E.A., Gan, T.“…Risk factors associated with non-response to COVID-19 vaccines were renal impairment, defined as EGFR < 60 ml/min/1,73 m2 (p = 0.007) and older age (p = 0.009). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99085por Peled, Y., Patel, J., Raanani, E., Segev, A., Matezki, S., Ram, E., Fardman, A., Beigel, R., Atari, N., Kliker, L., Elkader, B. Abd, Mandelboim, M., Afek, A.“…COVID-19 was associated with an increased risk of long-term renal dysfunction (OR 17.4, p<0.001), with the extent of deterioration correlating with the severity of acute COVID-19. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99086por Li, Yi, Toyama, Kaoru, Nakatsu, Takafumi, Ishizuka, Hitoshi, Wu, Hailan, Cao, Guoying, Yu, Jicheng, Wang, Yu, Liu, Xiaofen, Guo, Beining, Wu, Jufang, Yu, Peimin, Hong, Zhen, Zhang, Jing, Wu, Xiaojie“…The mean cumulative amount excreted into urine up to 48 h post-dose increased in a dose-proportional manner, the mean cumulative percentage excreted into urine was 61.9%–74.3%, and renal clearance remained relatively constant. CONCLUSION: Consistent with previous phase I studies in other populations, mirogabalin was safe and well tolerated in healthy Chinese participants at single and multiple doses of up to 15 mg twice-daily.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99087por Ushida, Takahiro, Katayama, Yoichi, Hiasa, Yoichi, Nishihara, Makoto, Tajima, Fumihiro, Katoh, Shinsuke, Tanaka, Hirotaka, Maeda, Takeshi, Furusawa, Kazunari, Richardson, Mary, Kakehi, Yoshihiro, Kikumori, Kunika, Kuroha, Masanori“…Patients with moderate renal impairment received half the dosage. The primary efficacy endpoint was change from baseline in the weekly average daily pain score (ADPS) at week 14. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99088por Nguyen, Bach, Duong, Minh Cuong, Diem Tran, Huynh Ngoc, Do, Kim Que, Nguyen, Kim Thai Thien“…There is a growing interest in AVF creations performed by nephrologists to help reduce vascular surgeons’ workload and enhance the timely treatment of patients with end-stage renal disease (ESRD). However, little is known about the feasibility and effectiveness of this approach in the low-resource settings. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99089“…RESULTS: More patients in the non-survivors had renal impairment, neurological manifestations, multiplasmatic cavity effusion and gastrointestinal manifestations compared to the survivors (p < 0.05). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99090por Norhammar, Anna, Bodegard, Johan, Vanderheyden, Marc, Tangri, Navdeep, Karasik, Avraham, Maggioni, Aldo Pietro, Sveen, Kari Anne, Taveira-Gomes, Tiago, Botana, Manuel, Hunziker, Lukas, Thuresson, Marcus, Banerjee, Amitava, Sundström, Johan, Bollmann, Andreas“…We designed the CardioRenal and Metabolic disease (CaReMe) HF study to estimate the prevalence, key clinical adverse outcomes and costs of HF across 11 countries. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99091por Liou, Ashley A., Anderson, Braden, Whitehurst, Courtney, Roman, Sabine, Beltran, Christian, Acton, Tayler, Foster, Jeannine, Nwokem, Obinna, Mogri, Idrees, Hammonds, Kendall, White, Heath D., Arroliga, Alejandro C., Ghamande, Shekhar“…BACKGROUND: The RAPID [Renal (urea), Age, fluid Purulence, Infection source, Dietary (albumin)] score is a validated scoring system which allows risk stratification in patients with pleural infection at presentation. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99092por Corvest, Victoria, Marec‐Bérard, Perrine, Lervat, Cyril, Pacquement, Hélène, Toulmonde, Maud, Gentet, Jean‐Claude, Laurence, Valérie, Cleirec, Morgane, Mansuy, Ludovic, Bompas, Emmanuelle, Castex, Marie‐Pierre, Taque, Sophie, Filhon, Bruno, Tabone, Marie‐Dominique, Verité, Cécile, Entz‐Werle, Natacha, Saumet, Laure, Guimard, Gregory, Pondrom, Morgane, Chevreau, Christine, Flandrin, Jennifer, Duranteau, Lise, Rousset‐Jablonski, Christine, Brugières, Laurence, Jimenez, Marta, Le Deley, Marie‐Cécile, Gaspar, Nathalie, Fresneau, Brice“…Of 267 French randomized patients, 204 were alive and free‐of‐relapse at 5‐years including 172 with available long‐term follow‐up data concerning cardiac, renal and/or gonadal functions (sex‐ratio M/F = 1.3, median age at diagnosis = 14 years): 84 randomized in VAC (median cumulative doses: cyclophosphamide = 9.7 g/m(2), ifosfamide = 59.4 g/m(2)) and 88 in VAI (ifosfamide = 97.1 g/m(2)). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99093por Forouzannia, Seyed Mohammad, Forouzannia, Seyed Khalil, Yarahmadi, Pourya, Alirezaei, Mohammad, Shafiee, Akbar, Anari, Negin Yazdian, Masoudkabir, Farzad, Dehghani, Zahra, Pashang, Mina“…The secondary outcomes were postoperative infection, ventilation time, ICU admission duration, hospital stay length, and renal failure after surgery. RESULTS: The median follow-up duration was 31.2 months (range 24.6–35.2 months). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99094por Lin, Keke, Wei, Changyun, Li, Jiaqi, Guo, Xuejie, Gao, Fengli, Zhao, Peiyu, Liu, Hongxia“…The score of the scale was positively associated with that of the Self-Management Scale of Renal Transplant Recipients (r = 0.532). Cronbach’s alpha was 0.959 for the entire scale and 0.956–0.958 for the three subscales. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99095por Huang, Qian, An, Ziming, Xin, Xin, Sun, Qinmei, Gao, Siting, Lv, Sheng, Xu, Xiao, Yang, Shuohui, Lu, Fang, Yuan, Jie, Zhao, Yu, Hu, Yiyang, Liu, Ping, Feng, Qin“…The safety of DGSY will be evaluated by renal function, routine blood and urine tests, and electrocardiogram. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99096por Carbonara, Cinthia E. M., Roza, Noemi A. V., Quadros, Kelcia R. S., França, Renata A., Esteves, André B. A., Pavan, Celia R., Barreto, Joaquim, dos Reis, Luciane M., Jorgetti, Vanda, Sposito, Andrei C., Oliveira, Rodrigo Bueno“…CONCLUSIONS: An elevated proportion of patients have bone Al accumulation, associated with a greater prevalence of bone pain, tendon rupture, and pruritus; bone Al accumulation was associated with minor perturbations in renal osteodystrophy; actual/prior diagnosis of bone Al accumulation and diabetes mellitus were independent predictors for MACE.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99097por Xu, Lujun, Cai, Juan, Li, Chenrui, Yang, Ming, Duan, Tongyue, Zhao, Qing, Xi, Yiyun, Sun, Liya, He, Liyu, Tang, Chengyuan, Sun, Lin“…In vitro experiments, BUMPT cells, a murine renal tubular cell line, were conducted to examine the effects of 4-OI on inflammation, oxidative stress, and mitophagy. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99098por Cinarli Yuksel, Feride, Nicolaou, Paschalis, Spontarelli, Kerri, Dohrn, Maike F., Rebelo, Adriana P., Koutsou, Pantelitsa, Georghiou, Anthi, Artigas, Pablo, Züchner, Stephan L., Kleopa, Kleopas A., Christodoulou, Kyproula“…Besides neuropathy, other associated phenotypes are spastic paraplegia, intellectual disability, and renal hypomagnesemia. We hereby report the first demyelinating CMT case due to a novel ATP1A1 variant. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99099por Tavakoli, Nader, Nafissi, Nahid, Shokri, Sima, Fallahpour, Morteza, Soleimani, Sanaz, Riahi, Taghi, Kalantari, Saeed, Goodarzi, Azadeh, Valizadeh, Rohollah“…CONCLUSION: The cardiovascular and hematological, joint-related (non-neurologic musculoskeletal) and dermatological side effects after the Soberana vaccine appear earlier and end later compared with the Sinopharm vaccine. Improvement of renal side effects in the Sinopharm vaccine group and improvement of neurological and respiratory side effects in the Soberana vaccine group occurred with delay compared with other vaccines.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99100por Xu, Yingjie, Luo, Lingfeng, Su, Gaixiu, Zhu, Jia, Kang, Min, Zhang, Dan, Lai, Jianming, Li, Xiaohui“…TAK patients with CAL had significantly higher CRP,WBC, PLT,TNF-α and IL-2R levels (P < 0.05), lower HGB (P = 0.01), lower rate of renal artery stenosis (RAS) (P = 0.009). In multivariate logistic regression, the risk factors for pediatric TAK combined with CAL included the age of TAK onset (OR = 0.9835, 95% CI: 0.9710–0.9946, P = 0.006) and RAS (OR = 0.1901, 95% CI: 0.0386–0.7503, P = 0.03). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto